-
1
-
-
79961105309
-
Developing a construct to evaluate flares in rheumatoid arthritis: A conceptual report of the OMERACT RA flare definition working group
-
Alten R, Pohl C, Choy EH, Christensen R, Furst DE, Hewlett SE, et al. Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group. J Rheumatol 2011;38:1745-50.
-
(2011)
J Rheumatol
, vol.38
, pp. 1745-1750
-
-
Alten, R.1
Pohl, C.2
Choy, E.H.3
Christensen, R.4
Furst, D.E.5
Hewlett, S.E.6
-
2
-
-
79961108254
-
Identifying preliminary domains to detect and measure rheumatoid arthritis flares: Report of the OMERACT 10 RA flare workshop
-
Bingham CO 3rd, Alten R, Bartlett SJ, Bykerk VP, Brooks PM, Choy E, et al. Identifying preliminary domains to detect and measure rheumatoid arthritis flares: report of the OMERACT 10 RA Flare Workshop. J Rheumatol 2011;38:1751-8.
-
(2011)
J Rheumatol
, vol.38
, pp. 1751-1758
-
-
Bingham, C.O.1
Alten, R.2
Bartlett, S.J.3
Bykerk, V.P.4
Brooks, P.M.5
Choy, E.6
-
3
-
-
70450179790
-
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 special interest group)
-
Bingham CO 3rd, Pohl C, Woodworth TG, Hewlett SE, May JE, Rahman MU, et al. Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group). J Rheumatol 2009;36:2335-41.
-
(2009)
J Rheumatol
, vol.36
, pp. 2335-2341
-
-
Bingham, C.O.1
Pohl, C.2
Woodworth, T.G.3
Hewlett, S.E.4
May, J.E.5
Rahman, M.U.6
-
4
-
-
84897405227
-
Establishing a core domain set to measure rheumatoid arthritis flares: Report of the OMERACT 11 RA flare workshop
-
Bykerk VP, Lie E, Bartlett SJ, Alten R, Boonen A, Christensen R, et al. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop. J Rheumatol 2014;41:799-809.
-
(2014)
J Rheumatol
, vol.41
, pp. 799-809
-
-
Bykerk, V.P.1
Lie, E.2
Bartlett, S.J.3
Alten, R.4
Boonen, A.5
Christensen, R.6
-
5
-
-
84902549977
-
Developing core outcome measurement sets for clinical trials: Omeract filter 2.0
-
Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol 2014;67:745-53.
-
(2014)
J Clin Epidemiol
, vol.67
, pp. 745-753
-
-
Boers, M.1
Kirwan, J.R.2
Wells, G.3
Beaton, D.4
Gossec, L.5
D'Agostino, M.A.6
-
6
-
-
84895444749
-
How to choose core outcome measurement sets for clinical trials: Omeract 11 approves filter 2.0
-
Boers M, Kirwan JR, Gossec L, Conaghan PG, D'Agostino MA, Bingham CO 3rd, et al. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0. J Rheumatol 2014;41:1025-30.
-
(2014)
J Rheumatol
, vol.41
, pp. 1025-1030
-
-
Boers, M.1
Kirwan, J.R.2
Gossec, L.3
Conaghan, P.G.4
D'Agostino, M.A.5
Bingham, C.O.6
-
7
-
-
58949093097
-
Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: A systematic literature review
-
Kalyoncu U, Dougados M, Daurès JP, Gossec L. Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2009;68:183-90.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 183-190
-
-
Kalyoncu, U.1
Dougados, M.2
Daurès, J.P.3
Gossec, L.4
-
8
-
-
38149067809
-
Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): A double-blind, randomised controlled trial
-
Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial. Lancet 2008;371:205-14.
-
(2008)
Lancet
, vol.371
, pp. 205-214
-
-
Buttgereit, F.1
Doering, G.2
Schaeffler, A.3
Witte, S.4
Sierakowski, S.5
Gromnica-Ihle, E.6
-
9
-
-
84872061599
-
Low-dose prednisone chronotherapy for rheumatoid arthritis: A randomised clinical trial (CAPRA-2)
-
Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis 2013; 72:204-10.
-
(2013)
Ann Rheum Dis
, vol.72
, pp. 204-210
-
-
Buttgereit, F.1
Mehta, D.2
Kirwan, J.3
Szechinski, J.4
Boers, M.5
Alten, R.E.6
-
10
-
-
0028793834
-
Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial
-
Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 1995;38:1568-80.
-
(1995)
Arthritis Rheum
, vol.38
, pp. 1568-1580
-
-
Buchbinder, R.1
Bombardier, C.2
Yeung, M.3
Tugwell, P.4
-
11
-
-
85007188871
-
"Stiffness has different meanings, I think, to everyone": Examining stiffness from the perspective of people living with rheumatoid arthritis
-
Orbai AM, Smith KC, Bartlett SJ, De Leon E, Bingham CO, 3rd. "Stiffness has different meanings, I think, to everyone": examining stiffness from the perspective of people living with rheumatoid arthritis. Arthritis Care Res 2014;66:1662-72.
-
(2014)
Arthritis Care Res
, vol.66
, pp. 1662-1672
-
-
Orbai, A.M.1
Smith, K.C.2
Bartlett, S.J.3
De Leon, E.4
Bingham, C.O.5
-
12
-
-
84926467248
-
Stiffness is more than just duration and severity: A qualitative exploration in people with rheumatoid arthritis
-
Sep 16 (E-pub ahead of print)
-
Halls S, Dures E, Kirwan J, Pollock J, Baker G, Edmunds A, et al. Stiffness is more than just duration and severity: a qualitative exploration in people with rheumatoid arthritis. Rheumatology 2014 Sep 16 (E-pub ahead of print).
-
(2014)
Rheumatology
-
-
Halls, S.1
Dures, E.2
Kirwan, J.3
Pollock, J.4
Baker, G.5
Edmunds, A.6
-
13
-
-
80055007179
-
Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: Ispor PRO good research practices task force report: Part 1-eliciting concepts for a new PRO instrument
-
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 1-eliciting concepts for a new PRO instrument. Value Health 2011;14:967-77.
-
(2011)
Value Health
, vol.14
, pp. 967-977
-
-
Patrick, D.L.1
Burke, L.B.2
Gwaltney, C.J.3
Leidy, N.K.4
Martin, M.L.5
Molsen, E.6
-
14
-
-
82955193739
-
Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: Ispor PRO good research practices task force report: Part 2-assessing respondent understanding
-
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity-establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2-assessing respondent understanding. Value Health 2011;14:978-88.
-
(2011)
Value Health
, vol.14
, pp. 978-988
-
-
Patrick, D.L.1
Burke, L.B.2
Gwaltney, C.J.3
Leidy, N.K.4
Martin, M.L.5
Molsen, E.6
-
15
-
-
84855183072
-
'I'm hurting, I want to kill myself': Rheumatoid arthritis flare is more than a high joint count - An international patient perspective on flare where medical help is sought
-
Hewlett S, Sanderson T, May J, Alten R, Bingham CO, 3rd, Cross M, et al. 'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count-an international patient perspective on flare where medical help is sought. Rheumatology 2012;51:69-76.
-
(2012)
Rheumatology
, vol.51
, pp. 69-76
-
-
Hewlett, S.1
Sanderson, T.2
May, J.3
Alten, R.4
Bingham, C.O.5
Cross, M.6
-
16
-
-
84867401156
-
Identifying core domains to assess flare in rheumatoid arthritis: An OMERACT international patient and provider combined delphi consensus
-
Bartlett SJ, Hewlett S, Bingham CO, 3rd, Woodworth TG, Alten R, Pohl C, et al. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis 2012;71:1855-60.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 1855-1860
-
-
Bartlett, S.J.1
Hewlett, S.2
Bingham, C.O.3
Woodworth, T.G.4
Alten, R.5
Pohl, C.6
-
17
-
-
84897834951
-
It's like a juggling act: Rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes
-
Flurey CA, Morris M, Richards P, Hughes R, Hewlett S. It's like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes. Rheumatology 2014;53:696-703.
-
(2014)
Rheumatology
, vol.53
, pp. 696-703
-
-
Flurey, C.A.1
Morris, M.2
Richards, P.3
Hughes, R.4
Hewlett, S.5
-
18
-
-
79551715973
-
The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases
-
Sanderson TC, Hewlett SE, Flurey C, Dures E, Richards P, Kirwan JR. The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases. J Rheumatol 2011;38:191-4.
-
(2011)
J Rheumatol
, vol.38
, pp. 191-194
-
-
Sanderson, T.C.1
Hewlett, S.E.2
Flurey, C.3
Dures, E.4
Richards, P.5
Kirwan, J.R.6
|